AREDS II supplementation is shown to slow progression in which AMD category?

Prepare for the NBEO Part III Test with detailed quizzes on patient encounters and performance skills. Access flashcards and questions with explanations to enhance your study strategy. Perfect your skills for exam success!

Multiple Choice

AREDS II supplementation is shown to slow progression in which AMD category?

Explanation:
AREDS2 is aimed at people with moderate (intermediate) AMD in one or both eyes and looks at whether adding antioxidants and minerals can slow the eye’s progression to the advanced forms of AMD. The study found that this supplementation reduces the chance of progressing to advanced AMD (the neovascular or geographic atrophy forms) in those with moderate disease, helping to delay vision decline. It does not apply to early AMD, and once AMD is already in an advanced stage, this supplementation isn’t shown to reverse or substantially slow progression. So the best match is moderate AMD.

AREDS2 is aimed at people with moderate (intermediate) AMD in one or both eyes and looks at whether adding antioxidants and minerals can slow the eye’s progression to the advanced forms of AMD. The study found that this supplementation reduces the chance of progressing to advanced AMD (the neovascular or geographic atrophy forms) in those with moderate disease, helping to delay vision decline. It does not apply to early AMD, and once AMD is already in an advanced stage, this supplementation isn’t shown to reverse or substantially slow progression. So the best match is moderate AMD.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy